Nuvectis Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 May 24 | BuyUS$13,076 | Ron Bentsur | Individual | 1,940 | US$6.74 | |
10 May 24 | BuyUS$7,034 | Shay Shemesh | Individual | 1,113 | US$6.32 | |
10 May 24 | BuyUS$3,145 | Enrique Poradosu | Individual | 500 | US$6.29 | |
10 May 24 | BuyUS$12,800 | Ron Bentsur | Individual | 2,000 | US$6.40 | |
18 Mar 24 | BuyUS$51,450 | Ron Bentsur | Individual | 5,000 | US$10.29 | |
10 Oct 23 | BuyUS$7,091 | Ron Bentsur | Individual | 640 | US$11.08 | |
09 Oct 23 | BuyUS$12,105 | Ron Bentsur | Individual | 1,080 | US$11.27 | |
05 Oct 23 | BuyUS$35,455 | Ron Bentsur | Individual | 3,220 | US$11.09 | |
16 Aug 23 | BuyUS$5,112 | Ron Bentsur | Individual | 350 | US$15.15 | |
11 Aug 23 | BuyUS$4,418 | Ron Bentsur | Individual | 300 | US$14.83 | |
31 Jul 23 | BuyUS$11,937 | Charles Mosseri-Marlio | Individual | 860 | US$13.88 | |
28 Jul 23 | BuyUS$35,943 | Charles Mosseri-Marlio | Individual | 2,584 | US$13.91 |
Insider Trading Volume
Insider Buying: NVCT insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 2,508,129 | 13.7% |
General Public | 3,839,975 | 20.9% |
Individual Insiders | 12,007,956 | 65.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,066,424 | US$20.3m | 1.45% | no data | |||
2,595,000 | US$17.2m | 0% | no data | |||
2,380,176 | US$15.8m | 0% | no data | |||
1,407,652 | US$9.3m | 4.36% | no data | |||
1,396,401 | US$9.2m | 6.03% | no data | |||
917,400 | US$6.1m | 0% | 2.24% | |||
908,475 | US$6.0m | 0% | no data | |||
372,721 | US$2.5m | -3.91% | no data | |||
298,800 | US$2.0m | 1.53% | no data | |||
168,630 | US$1.1m | 9.41% | 0.09% | |||
134,528 | US$890.6k | 2.18% | no data | |||
129,379 | US$856.5k | 9.38% | no data | |||
103,140 | US$682.8k | 41% | no data | |||
83,760 | US$554.5k | 55.8% | no data | |||
62,097 | US$411.1k | 0.85% | no data | |||
61,700 | US$408.5k | 19.1% | no data | |||
57,828 | US$382.8k | 108% | no data | |||
50,068 | US$331.5k | 102% | no data | |||
41,142 | US$272.4k | 80.1% | no data | |||
39,501 | US$261.5k | 16.1% | no data | |||
39,282 | US$260.0k | 43.8% | 0.02% | |||
34,000 | US$225.1k | 0% | 0.02% | |||
19,920 | US$131.9k | 0% | no data | |||
19,170 | US$126.9k | 0% | no data | |||
17,755 | US$117.5k | -7.28% | no data |